Williams, Thomas
Kalinka, Kevin
Sanches, Rui
Blanchard-Emmerson, Greg
Watts, Samuel
Davies, Lee
Knevelman, Carol
McCloskey, Laura
Jones, Peter
Mitrophanous, Kyriacos
Miskin, James
Dikicioglu, Duygu
Funding for this research was provided by:
Engineering and Physical Sciences Research Council (EP/L01520X/1, EP/L01520X/1)
Innovate UK (103940, 103940, 103940, 103940, 103940, 103940, 103940, 103940, 103940, 103940)
Swiss-European Mobility Programme
Article History
Received: 26 August 2022
Accepted: 11 January 2023
First Online: 16 January 2023
Competing interests
: The authors declare the following competing interests. T.W., R.S., L.D., C.K., L.M., P.J., K.M. and J.M. were all employees and stock option holders of Oxford Biomedica (UK) Limited at the time the research was conducted. G.B.-E. and S.W. were both co-founders and employees of WattBE Innovations Limited at the time the research was conducted. G.B.-E. and S.W. are listed as inventors of the, now lapsed, patent entitled “Method, system and controller for process control in a bioreactor” (patent number WO 2016/041775 A1). The remaining authors declare no competing interests.